MedPath

AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)

Completed
Conditions
Kidney Failure
Registration Number
NCT00780845
Lead Sponsor
Hospital de Base
Brief Summary

The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.

Detailed Description

Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
817
Inclusion Criteria
  • Patients underwent on-pump coronary artery bypass grafting
  • Patients with at least two serum creatinine values within 48 hours.
Exclusion Criteria
  • Patients with end-stage kidney disease requiring renal replacement therapy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To test the hypothesis that patients with acute kidney injury after on-pump CABG have higher 30-day mortality30 days
Secondary Outcome Measures
NameTimeMethod
To compare clinical outcomes in patients with and without acute kidney injury after on-pump CABG30 days
© Copyright 2025. All Rights Reserved by MedPath